Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001267550.2(TTN):c.100587G>A(p.Trp33529Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,613,438 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
TTN (HGNC:12403): (titin) This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]
TTN-AS1 (HGNC:44124): (TTN antisense RNA 1) This gene encodes a non-coding RNA transcribed from the opposite strand to the titin gene. [provided by RefSeq, Aug 2016]
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-178536160-C-T is Pathogenic according to our data. Variant chr2-178536160-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 418978.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178536160-C-T is described in Lovd as [Pathogenic].
Autosomal recessive limb-girdle muscular dystrophy type 2J Pathogenic:1
Likely pathogenic, criteria provided, single submitter
clinical testing
Baylor Genetics
Nov 21, 2022
- -
TTN-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided
clinical testing
PreventionGenetics, part of Exact Sciences
Jan 05, 2024
The TTN c.100587G>A variant is predicted to result in premature protein termination (p.Trp33529*). This variant has been reported in patients with TTN-related conditions (Ware et al. 2021. PubMed ID: 33906374; Choi et al. 2018. PubMed ID: 30535219). This variant is reported in 0.013% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is located in the A-Band and RNAseq studies from heart tissue indicate this exon is commonly included in TTN mRNA transcripts, demonstrating its clinical relevance (PSI of 100%, Roberts A.M. et al. 2015. PMID: 25589632; https://cardiodb.org/titin/titin_transcripts.php). Nonsense variants in this region of TTN are expected to be pathogenic. In the heterozygous state, early termination changes in the vicinity typically contribute to autosomal dominant cardiac-related phenotypes, whereas in combination with a second pathogenic variant in trans, they are associated with autosomal recessive muscular dystrophy phenotypes (Savarese et al. 2018. PubMed ID: 29435569). This variant is interpreted as pathogenic. -
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Pathogenic:1
Likely pathogenic, criteria provided, single submitter
clinical testing
Labcorp Genetics (formerly Invitae), Labcorp
Jul 20, 2023
This premature translational stop signal has been observed in individual(s) with clinical features of TTN-related conditions (PMID: 30535219, 33906374, 34495297; Invitae). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant is located in the A band of TTN (PMID: 25589632). Truncating variants in this region are significantly overrepresented in patients affected with dilated cardiomyopathy (PMID: 25589632). Truncating variants in this region have also been reported in individuals affected with autosomal recessive centronuclear myopathy (PMID: 23975875). ClinVar contains an entry for this variant (Variation ID: 418978). This variant is present in population databases (no rsID available, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Trp33529*) in the TTN gene. While this is not anticipated to result in nonsense mediated decay, it is expected to create a truncated TTN protein. -
Dilated cardiomyopathy 1G Pathogenic:1
Likely pathogenic, criteria provided, single submitter
clinical testing
Baylor Genetics
Nov 21, 2022
- -
Early-onset myopathy with fatal cardiomyopathy Pathogenic:1
Likely pathogenic, criteria provided, single submitter
clinical testing
Baylor Genetics
Nov 21, 2022
- -
Hypertrophic cardiomyopathy 9 Pathogenic:1
Likely pathogenic, criteria provided, single submitter
clinical testing
Baylor Genetics
Nov 21, 2022
- -
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1838244:Tibial muscular dystrophy;C1858763:Dilated cardiomyopathy 1G;C1861065:Hypertrophic cardiomyopathy 9;C1863599:Myopathy, myofibrillar, 9, with early respiratory failure;C2673677:Early-onset myopathy with fatal cardiomyopathy Pathogenic:1
Likely pathogenic, criteria provided, single submitter
clinical testing
Fulgent Genetics, Fulgent Genetics
Feb 22, 2022
- -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter
clinical testing
GeneDx
Nov 07, 2023
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Located in the A-band region of TTN in which the majority of loss of function variants have been associated with autosomal dominant titinopathies (PMID: 22335739); This variant is associated with the following publications: (PMID: 33226272, 22335739, 30535219, 34495297, 33906374, 29691892) -
Tibial muscular dystrophy Pathogenic:1
Likely pathogenic, criteria provided, single submitter
clinical testing
Baylor Genetics
Nov 21, 2022
- -
Myopathy, myofibrillar, 9, with early respiratory failure Pathogenic:1
Likely pathogenic, criteria provided, single submitter
clinical testing
Baylor Genetics
Nov 21, 2022
- -
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter
clinical testing
Ambry Genetics
Apr 18, 2024
The p.W24464* variant (also known as c.73392G>A), located in coding exon 184 of the TTN gene, results from a G to A substitution at nucleotide position 73392. This changes the amino acid from a tryptophan to a stop codon within coding exon 184. This exon is located in the A-band region of the N2-B isoform of the titin protein and is constitutively expressed in TTN transcripts (percent spliced in or PSI 100%). This alteration, also referred to as p.Trp33529* c.100587G>A , has been detected in an atrial fibrillation cohort and was reported to co-occur in trans with a TTN canonical I-band variant in a case with pediatric-onset cardiomyopathy from a cohort of patients with early onset hypotonia and/or congenital contractures (Choi SH et al. JAMA, 2018 12;320:2354-2364; Oates EC. Ann Neurol. 2018 Jun;83(6):1105-1124). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. While truncating variants in TTN are present in 1-3% of the general population, truncating variants in the A-band are the most common cause of dilated cardiomyopathy (DCM) (Herman DS et al. N. Engl. J. Med., 2012 Feb;366:619-28; Roberts AM et al. Sci Transl Med, 2015 Jan;7:270ra6). TTN truncating variants encoded in constitutive exons (PSI >90%) have been found to be significantly associated with DCM regardless of their position in titin (Schafer S et al. Nat. Genet., 2017 01;49:46-53). Based on the majority of available evidence to date, this variant is likely to be pathogenic. -